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There are several limitations in using absolute myo-
cardial clearance of thallium-201 for the detection of
coronary artery disease. Noncardiac factors such as peak
exercise heart rate and blood level of thallium can affect
its absolute myocardial clearance. However, because all
myocardial segments in a given heart are exposed to the
same noncardiac factors, a relative difference in myo-
cardial clearance of thallium between segments could
reflect the presence of coronary artery disease. Accord-
ingly, myocardial clearance of thallium was analyzed in
370 patients. Patients in Group I (n =45) had less than
1% probability of having coronary artery disease, pa-
tients in Group II (n =44) had normal coronary arteries
and patients in Group III (n =281)had coronary artery
disease. Although mean myocardial clearance of thal-
lium in 15 myocardial segments in three viewsin Group
I subjects was 3.4 ± 0.7 hours, the variability between
the slowest and fastest clearing segments in the same
subject was as much as 98%. This variability was sys-
tematic, suggesting technical reasons associated with im-
aging as the cause of the variability: 78% of the slowest
clearing segments were basal whereas 53% of the fastest
clearing segments were apical (p < 0.01).
When Group II and III patients were compared based
The hallmark of coronary disease on myocardial thallium
imaging is a relative perfusion defect (1-3). However, the
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on Group I values, the absolute myocardial clearance of
thallium had a sensitivity and specificityof 92 and 16%,
respectively. However, when myocardial clearance of
thallium was considered abnormal in a segment only if
the rate was 98% slower than that in the fastest clearing
segment in the same patient, sensitivity and specificity
changed to 69 and 86%, respectively (p < 0.01). When
the latter values were provided for logistic regression
analysis, myocardial clearance of thallium was at par
with redistribution and lung/heart ratio for the detection
of coronary artery disease.
In conclusion: 1) there is significant regional varia-
bility in the myocardial clearance of thallium, even in
normal subjects, probably as a result of factors related
to imaging techniques; 2) when myocardial clearance of
thallium is considered abnormal after comparison with
the fastest clearing segment in the myocardium, its di-
agnostic utility improves significantly; and 3) although
the initial impetus for using myocardial clearance of
thallium to detect coronary artery disease was its ability
to measure absolute values, its use as a relative variable
optimizes its diagnostic utility.
(J Am Coli CardioI1986;8:95-100)
presence of a perfusion defect requires and presumes another
relatively normal region in the same heart for purposes of
comparison. Since the introduction of quantitative thallium
imaging, myocardial clearance of thallium measured from
serial images has been reported by some laboratories (4-7)
to be useful as an absolute marker of coronary artery disease
that is not dependent on adjacent activity.
Because myocardial and blood levels of thallium are in
equilibrium, the gradient between the two levels appears to
determine the rate of myocardial thallium clearance (7).
However, the blood level of thallium may be influenced by
factors other than those related to coronary blood flow,
including serum insulin and glucose levels, as well as the
muscle mass of the patient (8). As skeletal muscle is a major
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organ of thallium uptake, serum levels of thallium may be
lower in patients with larger muscle mass. In addition, we
have previously demonstrated (9) that peak exercise heart
rate influences the myocardial clearance of thallium, which
may be related to an increase in cardiac output at higher
heart rates that causes more thallium to be delivered to the
myocardium and provides a larger myocardial-blood thal-
lium gradient.
We hypothesized that it would be impossible to correct
for all the variables that may influence the myocardial clear-
ance of thallium in humans. However, as all segments in
the myocardium "see" the same amount of thallium in the
blood in any given patient, regional differences in thallium
clearance would probably be influenced by myocardial-spe-
cific factors such as myocardial blood flow and myocardial
cellular integrity. The present study was conducted to test
this hypothesis and determine whether we could improve
the predictive accuracy of myocardial clearance of thallium
for the detection of coronary artery disease using such an
approach.
Methods
Study patients. The study included 370 patients. Group
I comprised 45 subjects with less than I% probability of
having coronary artery disease who did not undergo cardiac
catheterization (10). These subjects were less than 45 years
of age, were asymptomatic, had a normal physical exami-
nation and normal rest and exercise electrocardiograms and
had achieved more than 85% of maximal predicted heart
rate on exercise. Group II comprised 44 patients with chest
pain who were found to have no or insignificant coronary
artery disease, normal wall motion and normal rest left
ventricular end-diastolic pressure during cardiac catheter-
ization. Group III comprised 281 patients with chest pain
and significant coronary artery disease documented at car-
diac catheterization. Significant coronary artery disease was
defined as 50% or greater luminal diameter narrowing of a
coronary artery or one of its major branches as assessed by
two experienced observers. Of the Group III patients, 129
had had a previous myocardial infarction. Two hundred one
patients were taking a beta-adrenergic blocking agent at the
time of the study whereas 213 were taking nitrates; none
were taking a calcium channel blocker.
Thallium imaging. All patients were exercised accord-
ing to the Bruce protocol. Baseline 12 lead electrocardio-
gram, heart rate and blood pressure were recorded at rest
and at each minute of exercise. Exercise was terminated
when either fatigue, angina, dyspnea, hypotension or severe
ventricular arrhythmia occurred. At peak exercise, 2 mCi
of thallium-201 was injected intravenously and the patient
was encouraged to exercise for an additional 45 to 60 sec-
onds. A single crystal scintillation camera (Technicare 420,
Technicare Corporation) with a general purpose collimator
was used to obtain initial (commencing at 5 minutes after
exercise) and delayed (3 to 4 hours after exercise) images
in the anterior, 50° left anterior oblique and 70° anterior
oblique views as previously described (11,12).
Image processing. Images were collected in a 64 X 64
word matrix and transferred to a minicomputer (VAX 11/780,
Digital Equipment Corporation). Images were then analyzed
and displayed with the assistance of a frame buffer (DeAnza
Systems) using a program implemented on the minicom-
puter. This program has been described in detail elsewhere
(II). In brief, after the operator defines an elliptical region
of interest around the left ventricle, registration of initial
and delayed images, background subtraction, segmentation
of the ventricle into five regions and display of initial re-
gional and delayed activity are performed automatically.
From these data, presence or absence of redistribution and
regional myocardial clearance of thallium are derived (II).
In addition, a quantitative estimate of the lung/heart ratio
of thallium is derived using a method we described previ-
ously (12).
Statistical analysis. All group values were expressed as
mean ± I SD. Normal values for regional initial and de-
layed activity and myocardial clearance of thallium were
derived from Group I subjects. The sensitivity and speci-
ficity of each variable were tested between Groups II and
III (patients without and with documented coronary artery
disease, respectively).
Myocardial clearance ofthallium was expressed in three
ways: I) As half-life of thallium in the myocardium in hours
derived from a monoexponential curve fitted to the average
initial and delayed segmental thallium activity (C.) (II). 2)
As half-life of thallium after correcting for peak exercise
heart rate (C2) . We have previously demonstrated that peak
exercise heart rate correlated with myocardial clearance of
thallium such that a decrease in heart rate by I from an
arbitrary rate of 183 resulted in an increase in half-life of
thallium (slowing of clearance) by 0.05 hours (9). 3) As a
percent of the lowest clearance value (fastest clearance) seen
in the 15 segments analyzed in the three views (C3) . C3
therefore determines how much slower any segmental clear-
ance value is as compared with the fastest clearance value
in the same heart. For example, if the lowest clearance value
in the 15 segments is 4 hours, a segment having a clearance
value of 8 hours will be considered to have a value 100%
slower than the lowest clearance value.
The sensitivity and specificity of C. and C2 were derived
by comparing the values in Groups II and III with those in
Group I. Any segmental clearance value higher than 2 stan-
dard deviations from the mean clearance value in the same
segment in Group I subjects was considered abnormal.
The variables provided for analysis were: I) presence of
initial thallium defect determined quantitatively, 2) presence
or absence of redistribution defined quantitatively, 3) quan-
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titative lung/heart ratio of thallium, 4) C" 5) Cz, and 6) C3 •
Segments demonstrating each of the abnormal quantitative
variables were added. Stepwise logistic regression analysis
was then performed to create a model to predict coronary
artery disease in a particular patient (13). This analysis was
used to determine I) which quantitative variables would be
entered into the model, and 2) what predictive power could
be achieved by combining different combinations of quan-
titative thallium variables. This analysis chooses the sig-
nificant variables and weighs each variable in relation to its
role in determining the probability of coronary artery dis-
ease. Each variable is assigned a chi-square value before
each step; the greater the chi-square value, the more im-
portant the variable in predicting coronary artery disease.
Variables are entered into the model in a stepwise manner
with the most important variable entered first. The model
is complete when no remaining variables have significant
chi-square values.
Results
Regional variability of thallium clearance in normal
subjects. In Group I, although the standard deviation of
mean myocardial clearance of thallium was small (3.38 ±
0.72 hours), the variability between the slowest and fastest
clearance in the same heart was as high as 98% (36 ±
13%). Therefore, in normal subjects, using our method of
computer quantitation, the half-life of thallium in the slowest
clearing myocardial segment could be twice as long as that
in the fastest clearing segment. Further, there was a sig-
nificant pattern seen in the variability suggesting technical
reasons for this apparent heterogeneity in the segmental
myocardial clearance of thallium (Fig. I). The slowest clear-
Figure 1. A, Illustrates the segments demonstrating the slowest
clearance of thallium in the 45 normal asymptomatic subjects.
Notethat mostof the segments (78%) that demonstrate the slowest
clearance are the basal segments. B, Illustrates the segments dem-
onstrating the fastestclearanceof thallium in the45 normal asymp-
tomatic subjects. Note that the segment that shows the fastest
clearance of thallium is commonly the apicalsegment(53% of the
cases).
A'~ @4 ~o4 3 3 0 2 3
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ance of thallium was seen in the basal segments in 78% of
the subjects (p < 0.01) whereas the fastest clearance of
thallium was seen in the apical segments in 53% of the
subjects (p < 0,0 I). On the basis of these data we identified
segments as demonstrating abnormal C3 clearance value in
Group II and III patients if the half-life of thallium in these
segments was greater than twice that of the fastest clearing
segment.
Abnormal thallium clearance in patients with chest
pain. The sensitivity and specificity of the three forms of
abnormal clearance (C" Cz and C3) for detecting coronary
artery disease are expressed in Table 1. Although abnormal
C, had the highest sensitivity for coronary disease, its spec-
ificity was poor. Abnormal Cz and abnormal C3 had sig-
nificantly higher specificity than abnormal C 1 but lower
sensitivity, The specificity of abnormal C3 was slightly but
not significantly higher than abnormal Cz. The sensitivity
of C3 was similar in patients with or without previous myo-
cardial infarction (62.8 versus 64.4%). When logistic
regression analysis was used, abnormal C3 was second only
to initial thallium defect as the variable having the highest
chi-square value (Table 2).
The othervariable included in the modelwas the lung/heart
ratio of thallium. The maximal overall correct prediction of
this model in the entire study group was 90% (coronary
artery disease was correctly predicted in 90% of cases and
absence of coronary artery disease was correctly predicted
in 82%). When 152 patients without previous myocardial
infarction were separately analyzed, both the overall correct
prediction and the correct prediction for presence and ab-
sence of coronary artery disease were similar to those of
the overall study group (84, 86 and 77%, respectively).
Comparison of clearance with lung/heart ratio of thal-
lium and with redistribution. When lung/heart ratio was
not included in the analysis, the overall correct predictions
and presence and absence of coronary artery disease cor-
rectly predicted by the model remained unchanged (Table
2). Similarly, when abnormal C3 clearance value was not
included, the analysis included redistribution instead, with
similar overall correct predictions and correct predictions
for presence or absence of coronary artery disease (Table
Table 1. Sensitivity and Specificity of the Three Different
Forms of Abnormal Clearance for the Detection of Coronary
Artery Disease
*p < 0.01. C, = uncorrected half-life of thallium; C2 = half-life of
thallium corrected for peak exercise; C3 = clearance in a segment heart
rate which is at least twice as slow as the fastest clearing segment in the
same heart.
NUMBER OF NORMAL SUBJECTS (TOTAL=45)
DEMONSTRATING SLOWEST CLEARANCE OF THALLlUM- 201
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Table 2. Results of Stepwise Logistic Regression Analyses
Absence of CAD
Variables Chi-Square Total Correct CAD Correctly Correctly
Input Selected Value Predictions (%)* Predicted (%)* Predicted (%)*
All variables Initial defect 51.8 90 90 82
C3 48.8
Lung/Heart Ratio 27.6
All variables except C3 Initial defect 66.0 88 89 80
Redistribution 46.5
All variables except Initial defect 66.6 88 90 77
lung/heart ratio C3 48.8
*No significant difference among the three analyses. CAD = coronary artery disease; C3 = abnormal clearance when compared with the fastest
clearing segment in the heart.
2). We have previously demonstrated (11) the sensitivity
and specificity of redistribution alone to be 60 and 91%,
respectively, and that of the initial defect to be 95 and 66%,
respectively. These data imply that second to initial thallium
defects, the C3 thallium clearance, the lung/heart ratio of
thallium and redistribution are equally important and can
thus be used interchangeably for predicting the presence or
absence of coronary artery disease in patients with chest
pain.
Discussion
Factors affecting myocardial clearance of thallium.
Using myocardial clearance of thallium in the detection of
coronary artery disease has several theoretic advantages.
Both the amount of thallium entering the myocardium and
the rate of clearance from the myocardium are related to
myocardial blood flow (6). Zones with the best perfusion
have the most thallium delivered initially and have the larg-
est myocardial-blood gradient resulting in the fastest clear-
ance. Zones with lower perfusion have less thallium deliv-
ered initially and clear more slowly (14).
Although myocardial clearance of thallium has been found
useful in the experimental setting (14-16), its derivation in
the clinical situation is more difficult because of several
factors. First, unlike the animal model where clearance is
derived either by continuous monitoring of myocardial thal-
lium activity using a cadmium telluride crystal mounted on
a probe (8,15), or by frequent biopsy of myocardial tissue
(16), clearance in the clinical setting is derived from activity
in only the initial and delayed images (4-6,9,11). Therefore,
there may not be enough data points over time to obtain a
true estimation of clearance. Second, there is relatively little
thallium activity in the myocardium, which, coupled with
the fact that thallium is a low energy gamma emitter that is
easily attenuated, increases the likelihood of statistical error
in the derivation of clearance. Third, unlike the animal
model where background is not a confounding problem,
planar thallium images require background subtraction
(4-6,9,11). Errors in background subtraction in either image
could significantly alter the slope of the clearance curve.
Fourth, because the cardiac output, and thus the coronary
flow response to exercise, varies from person to person, the
amount of thallium in the myocardium may differ greatly.
We have previously demonstrated (9) that there is an inverse
relation between the clearance of thallium and peak exercise
heart rate. Fifth, as skeletal muscle is a major organ of
thallium uptake, even for the same heart rate and cardiac
output, the serum level of thallium in different patients may
differ significantly, which will affect the clearance of thal-
lium from the myocardium.
In the present study we have demonstrated that even in
normal subjects with less than 1% probability of having
coronary artery disease, the derived clearance of thallium
may differ by 98% between one segment and another. In
this population, this finding cannot be explained by myo-
cardial-specific factors, coronary blood flow or serum levels
of thallium (because all myocardial segments in the same
subject are exposed to the same serum level of thallium).
These findings therefore probably represent errors in the
estimation of myocardial clearance of thallium from planar
thallium images. Basal segments tend to have slower clear-
ance rates whereas apical segments tend to have faster rates.
Such results should not be surprising considering the lim-
itations of measuring myocardial clearance of thallium from
planar thallium images. It seems likely that these limitations
may be overcome by single photon emission computed to-
mography (17,18). This technique provides tomographic
images of the myocardium, allowing better visualization and
separation of myocardial segments than are achieved by
planar imaging. Thus, it is likely that clearance values de-
rived using this technique have less variability than those
derived from planar images.
We previously demonstrated (9) a relation between myo-
cardial thallium clearance and peak exercise heart rate. Us-
ing a correction factor based on this relation, we improved
the specificity of myocardial clearance of thallium from 16
to 77% for detecting coronary artery disease (11). However,
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redistribution and the lung/heart ratio of thallium provide
better specificity and therefore are included in the logistic
regression model in preference to peak heart rate-corrected
thallium clearance. Therefore, the correction factor, al-
though important, is not a very useful clinical tool.
Value of relative rather than absolute clearance values
for detection of coronary artery disease. Because of the
regional differences in myocardial thallium clearance, we
derived a modified myocardial clearance (C3) value based
on the variability of clearance seen in normal humans. Using
C3 clearance, we not only were able to increase specificity
of clearance in the detection of coronary artery disease, but
also were able to bring clearance on a par with redistribution
and lung/heart ratio in the detection of coronary artery dis-
ease. We achieved this at the expense of sensitivity. How-
ever, because abnormal clearance of thallium in any par-
ticular segment is dependent on decreased uptake of thallium
in that segment, abnormal initial uptake should theoretically
beabnormal in all cases with abnormalclearance. Our method
for determining initial uptake is very sensitive (95%) for
the detection of coronary artery disease but has a specificity
of 66% (11). If any quantitative variable other than the
presence of initial thallium defects is to be of use in the
detection of coronary artery disease, it would require a higher
specificity.
Practical implications. The present study demonstrates
that the logistic regression model incorporated abnormal
clearance when compared with the fastest clearing segment
(C3) as an equally potent predictor of coronary artery disease
as either redistribution or lung/heart ratio of thallium. C3
clearance was as useful in the entire group of patients (with
and without previous myocardial infarction) as in the pa-
tients without previous myocardial infarction. These data
imply that either C3 clearance, lung/heart ratio of thallium
or quantitative redistribution can be used interchangeably
in conjuction with initial thallium defects to determine the
presence or absence of coronary artery disease. In addition,
our data demonstrate that inclusion of more than one of
these three variables does not further enhance the predictive
power of the model.
These results have important practical implications. Most
computer methods for analysis of thallium images do not
have methods of measuring the lung/heart ratio of thallium
or redistribution incorporated into them (4-6). Although the
former is easy to measure, quantitation of the latter is com-
plex (II). In addition, segmental clearance of thallium is
easy to derive from average thallium activity in the initial
and delayed images and can be easily incorporated into any
computer program that measures segmental thallium activ-
ity.
Summary. We have defined a method of optimizing
myocardial clearance of thallium in the detection of coronary
artery disease. This approach is based on the assumption
that at least 1 of the 15 myocardial segments in the three
views is normal. All myocardial segments are then com-
pared with this segment and any variability in the segmental
clearance greater than that seen in normal subjects is con-
sidered abnormal. Although the initial impetus for using
clearance as a method for detection of coronary artery dis-
ease was its ability to measure absolute half-life of thallium
in the myocardium, because of technical limitations asso-
ciated with planar imaging, its use as a relative variable
optimizes its diagnostic utility.
Addendum
Since this paper was submitted for publication, the effect
of hangup of thallium in the peripheral vein (site of injection)
on the myocardial clearance of thallium has been reported
(19). According to Gal et al. (19) thallium hangup (not
extravasation) was seen in 51% of their patients in whom
thallium was injected through a peripheral vein. The slow
release of thallium from the venous site probably altered
the blood level of thallium, resulting in changes in clearance
of thallium from the myocardium. This is a possible addi-
tional mechanism for the poor specificity of absolute re-
gional myocardial clearance values for the detection of coro-
nary artery disease.
We are grateful to Elizabeth Howk and John D. Oliner for editorial as-
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References
I. Bailey IK, Griffith LSC, Rouleau J, Strauss HW, Pitt B. Thallium-
201 myocardial perfusion imaging at rest and during exercise. Com-
parative sensitivity to electrocardiography in coronary artery disease.
Circulation 1977;55:79-87.
2. Ritchie JL, Trogaugh GB, Hamilton GW, et al. Myocardial imaging
with thallium-201 at rest and during exercise. Comparison with coro-
nary arteriography, and resting and stress electrocardiography. Cir-
culation 1977;56:66-71.
3. Botvinick EH, Taradesh MR, Hames DM, Parmley WW. Thallium-
20 I myocardial perfusion scintigraphy for the clinical classification
of normal, abnormal, and equivocal electrocardiographic stress tests.
Am J Cardiol 1978;41:41-51.
4. Maddahi J, GarciaEV, Berman DS, Waxman A, Swan HJC, Forrester
J. Improved noninvasive assessment of coronary artery disease by
quantitative analysis of regional stress myocardial uptake and washout
of thallium-20 I. Circulation 1981;64:924-35.
5. Bateman TM, Maddahi J, Gray RJ, et al. Diffuse slow washout of
myocardial thallium-20 I: a new scintigraphic indicator of extensive
coronary artery disease. J Am Coli Cardiol 1984;4:55-64.
6. Massie BM, Hollenberg M, Wisneski JA, Go M, Gertz EW, Hen-
derson S. Scintigraphic quantitation of myocardial ischemia: a new
approach. Circulation 1983;68:747-55.
7. Okada RD, Leppo J, Boucher CA, et al. Myocardial kinetics of thal-
lium-20l after dipyridamole infusion in normal canine myocardium
and in myocardium distal to a stenosis. J Clin Invest 1982;69:199-209.
100 KAUL ET AL.
OPTIMIZING MYOCARDIAL THALLIUM CLEARANCE
JACC Vol. 8, No. I
July 1986:95-100
8. Wilson RA, Okada RD, Strauss HW, Pohost GM. Effect of glucose-
insulin-potassium infusion of thallium myocardial clearance. Circu-
lation 1983;68:203-9.
9. Kaul S, Chesler DA, Pohost GM, Strauss HW, Okada RD, Boucher
CA. Influence of peak exercise heart rate on normal thallium myo-
cardial clearance. J Nucl Med 1986;27:26-30.
10. Diamond GA, Forrester JS. Analysis of probability as an aid in the
diagnosis of coronary artery disease. N Engl J Med 1979;300:1350-9.
II. Kaul S, Boucher CA, Newell JB, et al. Determination of the quan-
titative thallium imaging variables that optimize detection of coronary
artery disease. J Am Coli Cardiol 1986;7:527-37.
12. Boucher CA, Zir LM, Beller GA, et al. Increased lung uptake of
thallium-201 during exercise myocardial imaging: clinical, hemody-
namic and angiographic implications in patients with coronary artery
disease. Am J Cardiol 1980;46:189-96.
13. Dixon WJ, Brown MB, Engleman L, et al. BMDP Statistical Software.
Los Angeles: University of California Press, 1981:330-44.
14. Pohost GM, Zir LM, Moore RH, McCusick KA, Guiney TE, Beller
GA. Differentiation of transiently ischemic from infarcted myocar-
dium by serial imaging after a single dose of thallium-201. Circulation
1977;55:294-302.
15. Okada RD, Pohost GM. The use of pre-infarction and post-intervention
thallium imaging for assessing the early and late effects of experi-
mental coronary arterial reperfusion in dogs. Circulation 1984;
69:1153-60.
16. Beller GA, Watson DD, Ackell P, Pohost GM. Time course of thal-
lium-201 redistribution after transient myocardial ischemia. Circula-
tion 1980;61:791-7.
17. Takamaki N, Mukai T, Yasushi I, et al, Clinical evaluation of thallium-
201 emission myocardial tomography using a rotating gamma camera:
comparison with seven-pinhole tomography. J Nucl Med 1981;
22:849-55.
18. Maublant J, Cassagnes J, Lejeune JJ, et al. A comparison between
conventional scintigraphy and emission tomography with thallium-
201 in the detection of myocardial infarction: concise communication.
J Nucl Med 1982;23:204-8.
19. Gal R, Niazi I, Port S. Importance of the site and technique of intra-
venous thallium injection during exercise (abstr). J Am Coli Cardiol
1986;7:23a.
